Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Highlighted at the American Urological Association 2010 Annual Meeting
Six Abstracts Covering EDAP's Technologies to be Presented at AUA 2010
View HTML
Toggle Summary EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress
LYON, France , March 17, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its HIFU and lithotripsy devices were highlighted at the European Association of Urology (EAU) 2016 Annual Congress held in Munich, Germany , on March
View HTML
Toggle Summary EDAP HIFU Advancements Highlighted at International Symposium on Therapeutic Ultrasound
LYON, France , March 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its advancements in High Intensity Focused Ultrasound (HIFU) were highlighted at the International Symposium on Therapeutic Ultrasound (ISTU 2016), which
View HTML
Toggle Summary EDAP Heightens Participation in Global Urology Congresses
Supports Strategic Marketing Initiatives by Strong Presence at Major Events
View HTML
Toggle Summary EDAP Granted Special Temporary Reimbursement for Ablatherm-HIFU in France
LYON, France , Feb. 2, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today it has been granted a special temporary reimbursement for Ablatherm-HIFU for the treatment of localized prostate cancer by the French National Authority for Health
View HTML
Toggle Summary EDAP Granted European Market Clearance for Focal.One(R)
Positions Focal.One Robotic HIFU Device for Commercialization
View HTML
Toggle Summary EDAP German HIFU Tours Generate New Interest in Ablatherm-HIFU
Six-City Tour Generates Awareness, Training Demand for Ablatherm-HIFU TherapyEAU Congress Interest Advances German Market Growth
View HTML
Toggle Summary EDAP Generates First U.S. Sonolith i-move Lithotripter Sale
Empire Litho to Utilize Compact Lithotripter on Mobile Basis at Six New York City Metro Hospitals US Sale Recorded Three Months Following U.S. FDA 510(k) Clearance LYON, France , Nov. 10, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced it
View HTML
Toggle Summary EDAP Gains U.S. FDA 510(k) Lithotripter Clearance
Innovative Compact Sonolith(R) i-move Lithotripter Expands U.S. Market Potential
View HTML
Toggle Summary EDAP Fully Redeems $8.0 Million Long-Term Debt
Ablatherm-HIFU PMA Application Process Continues to Advance
View HTML